aldactone and heart remodeling buy paxil online canada effexor pills look like
price of adobe acrobat 9 in india download audition 3 adobe buy microsoft office 97
price of microsoft office 2013 in malaysia best price project 2013 upgrade cost of rosetta stone online subscription
viagra indien zoll forum vente viagra ligne cialis 5 precio
comprar kamagra en farmacia vente viagra cialis levitra comprare cialis in italia on line
  • kamagra oral jelly acheter viagra belgique sans ordonnance billig viagra danmark
  • where can i buy viagra online in australia how to obtain viagra in australia viagra forums australia
    400 mg celebrex per day nolvadex cheap online tamoxifen buy online uk

    Chicago ENT head and neck surgeons using VELscope Vx to enhance oral cancer surgery success rate

    Thu, Jan 10, 2013

    Oral Cancer News

    Source: www.menafn.com
    Author: press release

    LED Medical Diagnostics Inc. subsidiary LEDDental announced today that its VELscope Vx enhanced oral assessmentdevice will now be used by Chicago Otolaryngology Associates for oralmucosal abnormality assessment and when performing surgery on oral cancer patients.

    According to Chicago Otolaryngology Associates’ Howard Kotler, MD,FACS, “We pride ourselves on embracing state-of-the-art technologies that allow us to provide the best patient care possible. The VELscopeVx may significantly enhance our ability to see the entire cancerous or precancerous lesion that needs to be excised, allowing us to minimize risk of additional unnecessary surgery.”

    The VELscope Vx’s fluorescence visualization technology is the first approved by the FDA and Health Canada to help surgeons determine the surgical margins when excising cancerous and precancerous tissues. The technology is also approved to help dental and medical professionals discover cancerous and precancerous tissue that might not be apparent to the unaided eye.

    The vast majority of the nearly 12,000 VELscope devices in use around the world are used by dental practices. Typically, when a suspicious lesion is detected by a dentist, the patient is referred to an oral surgeon or a periodontist for a surgical biopsy, which is then evaluated by an oral pathologist. If the biopsy sample is determined to be cancerous or precancerous, the patient is usually referred to an ENT head and neck surgeon for consultation and likely excision. VELscope technology was developed to address the problem of detecting all abnormal tissue, including that beneath the surface, as well as making it possible for dentists to discover early stage oral cancer, which requires less invasive treatment and has a significantly higher chance of survival than when the disease is detected in late stages.

    “We applaud Dr. Kotler and Chicago Otolaryngology Associates forbeing one of the first Otolaryngology practices in the U.S. toincorporate VELscope’s potentially life-saving technology,” saidPeter Whitehead, founder and CEO of LED Dental and its parent, LEDMedical Diagnostics Inc. .

    Print Friendly
    Be Sociable, Share!
    , , , , ,

    Leave a Reply

    You must be logged in to post a comment.